Akari Therapeutics, Plc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.00 | -$1.00 | -$1.00 |
| Q2 2024 | 1 | -$0.60 | -$0.60 | -$0.60 |
| Q3 2024 | 1 | -$1.00 | -$1.00 | -$1.00 |
Akari Therapeutics, Plc Earnings Date And Information
Akari Therapeutics, Plc last posted its earnings results on Tuesday, October 3rd, 2023. The company reported $-0.64958 earnings per share for the quarter, topping analysts' consensus estimates of $-1 by $0.35042. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Akari Therapeutics, Plc has generated $-2 earnings per share over the last year ($-2.04 diluted earnings per share) and currently has a price-to-earnings ratio of -0.81. Akari Therapeutics, Plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 19th, 2024 based on prior year's report dates.
Akari Therapeutics, Plc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/19/2024 | Q3 2024 | -$0.24 | $0 | $0 | ||
| 08/19/2024 | Q2 2024 | -$0.80 | $0 | $0 | ||
| 03/29/2024 | Q1 2024 | -$0.83 | $0 | |||
| 12/30/2023 | Q4 2023 | -$0.65 | $0 | |||
| 09/28/2023 | Q3 2023 | -$0.65 | $0 | |||
| 09/29/2023 | Q2 2023 | -$0.68 | $0 | |||
| 09/29/2023 | Q1 2023 | $0.27 | $0 | |||
| 12/30/2022 | Q4 2022 | -$1.01 | $0 | |||
| 07/20/2022 | Q3 2022 | -$1.01 | $0 | |||
| 05/17/2022 | Q2 2022 | -$0.09 | $0 | |||
| 05/17/2022 | Q1 2022 | -$0.10 | $0 | |||
| 12/03/2021 | Q4 2021 | -$0.12 | $0 | |||
| 12/03/2021 | Q3 2021 | -$0.03 | $0 | |||
| 04/20/2021 | Q2 2021 | -$0.11 | $0 | |||
| 04/20/2021 | Q1 2021 | -$3.04 | $0 | |||
| 12/11/2020 | Q4 2020 | -$5.19 | $0 | |||
| 12/11/2020 | Q3 2020 | $0.54 | $0 | |||
| 03/31/2020 | Q2 2020 | -$0.14 | -$5.54 | -5.4 | $0 | |
| 03/31/2020 | Q1 2020 | -$0.14 | -$2.69 | -2.55 | $0 | |
| 11/27/2019 | Q4 2019 | -$7.30 | $0 |
Akari Therapeutics, Plc Earnings: Frequently Asked Questions
-
When is Akari Therapeutics, Plc's earnings date?
Akari Therapeutics, Plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 19th, 2024 based off last year's report dates.
-
Did Akari Therapeutics, Plc beat their earnings estimates last quarter?
In the previous quarter, Akari Therapeutics, Plc (:AKTX) reported $-0.64958 earnings per share (EPS) to beat the analysts' consensus estimate of $-1 by $0.35042.
-
How can I listen to Akari Therapeutics, Plc's earnings conference call?
The conference call for Akari Therapeutics, Plc's latest earnings report can be listened to online.
-
How can I read Akari Therapeutics, Plc's conference call transcript?
The conference call transcript for Akari Therapeutics, Plc's latest earnings report can be read online.
-
How much profit does Akari Therapeutics, Plc generate each year?
Akari Therapeutics, Plc (:AKTX) has a recorded net income of $0. Akari Therapeutics, Plc has generated $-2.04 earnings per share over the last four quarters.
-
What is Akari Therapeutics, Plc's price-to-earnings ratio?
Akari Therapeutics, Plc (:AKTX) has a price-to-earnings ratio of -0.81 and price/earnings-to-growth ratio is -0.04.
